Abstract
The management of patients with posterior uveal melanoma involves detection, diagnosis, treatment, prognostication, counseling, surveillance, and, in some cases, treatment for metastatic disease. Each of these activities is advancing rapidly; however, many aspects of care remain controversial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Damato B. Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view. Prog Retin Eye Res. 2018;66:187.
Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119:1582–9.
Bove R, Char DH. Nondiagnosed uveal melanomas. Ophthalmology. 2004;111:554–7.
Eskelin S, Kivela T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol. 2002;86:333–8.
Afshar AR, Deiner M, Allen G, et al. The patient’s experience of ocular melanoma in the US: a survey of the ocular melanoma foundation. Ocul Oncol Pathol. 2018;4:280–90.
Damato BE. Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas. Eye. 1992;6(Pt 6):587–93.
Callejo SA, Dopierala J, Coupland SE, et al. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol. 2011;129:958–60.
Sen J, Groenewald C, Hiscott PS, et al. Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology. 2006;113:1028–31.
Kivela TT, Piperno-Neumann S, Desjardins L, et al. Validation of a prognostic staging for metastatic uveal melanoma: a collaborative Study of the European Ophthalmic Oncology Group. Am J Ophthalmol. 2016;168:217–26.
Feinstein EG, Marr BP, Winston CB, et al. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol. 2010;128:319–23.
Damato B, Heimann H. Personalized treatment of uveal melanoma. Eye. 2013;27:172–9.
Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–9.
Damato BE, Heimann H, Kalirai H, et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132:605–13.
Collaborative Ocular Melanoma Study G. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–93.
Damato B. Legacy of the collaborative ocular melanoma study. Arch Ophthalmol. 2007;125:966–8.
Gragoudas ES, Lane AM, Munzenrider J, et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43–8; discussion 48–49.
Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 1989;96:382–8.
Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111:977–83.
Stannard C, Sauerwein W, Maree G, et al. Radiotherapy for ocular tumours. Eye. 2013;27:119–27.
Reichstein D, Karan K. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications. Curr Opin Ophthalmol. 2018;29:191–8.
Russo A, Laguardia M, Damato B. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2012;250:1533–40.
Astrahan MA, Luxton G, Jozsef G, et al. An interactive treatment planning system for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:679–87.
Le BHA, Kim JW, Deng H, et al. Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review. Brachytherapy. 2018;17:981–9.
Konstantinidis L, Roberts D, Errington RD, et al. Transpalpebral proton beam radiotherapy of choroidal melanoma. Br J Ophthalmol. 2015;99:232–5.
Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:997–1010.
Damato BE, Stewart JM, Afshar AR, et al. Surgical resection of choroidal melanoma. In: Schachat AP, editor. Ryan’s retina, vol. 3. Philadelphia: Elsevier; 2018. p. 2591–600.
Konstantinidis L, Groenewald C, Coupland SE, et al. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol. 2014;98:775–9.
Reichstein D. Current treatments and preventive strategies for radiation retinopathy. Curr Opin Ophthalmol. 2015;26:157–66.
Matet A, Daruich A, Zografos L. Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity. Invest Ophthalmol Vis Sci. 2017;58:3851–61.
Zehetmayer M. Stereotactic photon beam irradiation of uveal melanoma. Dev Ophthalmol. 2012;49:58–65.
Schilling H, Bornfeld N, Talies S, et al. [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases]. Klinische Monatsblatter fur Augenheilkunde. 2006;223:513–20.
Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM, et al. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol. 1992;82:185–91.
Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109:225–34.
Damato B. Vasculopathy after treatment of choroidal melanoma. In: Joussen A, Gardner TW, Kirchhof B, Ryan SJ, editors. Retinal vascular disease. Berlin: Springer; 2007. p. 582–91.
Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013;27:163–71.
Jmor F, Hussain RN, Damato BE, et al. Photodynamic therapy as initial treatment for small choroidal melanomas. Photodiagn Photodyn Ther. 2017;20:175–81.
Kines RC, Varsavsky I, Choudhary S, et al. An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma. Mol Cancer Ther. 2018;17:565–74.
Wilson DJ, Klein ML. Cryotherapy as a primary treatment for choroidal melanoma. Arch Ophthalmol. 2002;120:400–3.
Konstantinidis L, Groenewald C, Coupland SE, et al. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol. 2014;98:82–5.
Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92:1013–4.
Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006;46:95–107.
Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410–3.
Damato B, Eleuteri A, Taktak AF, et al. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30:285–95.
Berry D, Seider M, Stinnett S, et al. Relationship of clinical features and baseline tumor size with gene expression profile status in uveal melanoma: a multi-institutional Study. Retina. 2018.
Vaquero-Garcia J, Lalonde E, Ewens KG, et al. PRiMeUM: a model for predicting risk of metastasis in uveal melanoma. Invest Ophthalmol Vis Sci. 2017;58:4096–105.
Hussain RN, Kalirai H, Groenewald C, et al. Prognostic biopsy of choroidal melanoma after proton beam radiation therapy. Ophthalmology. 2016;123:2264–5.
Eskelin S, Pyrhonen S, Summanen P, et al. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85:1151–9.
Marshall E, Romaniuk C, Ghaneh P, et al. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97:159–63.
Wen JC, Sai V, Straatsma BR, et al. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma. JAMA Ophthalmol. 2013;131:56–61.
Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol. 2012;153:661–8.
Strobel K, Bode B, Dummer R, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36:1774–82.
Diener-West M, Reynolds SM, Agugliaro DJ, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:2438–44.
Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152:5–9 e1.
Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010;128:871–5.
Komatsubara KM, Carvajal RD. Immunotherapy for the treatment of uveal melanoma: current status and emerging therapies. Curr Oncol Rep. 2017;19:45.
Whitehead J, Tishkovskaya S, O’Connor J, et al. Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. Invest Ophthalmol Vis Sci. 2012;53:4986–9.
Damato B, Hope-Stone L, Cooper B, et al. Patient-reported outcomes and quality of life after treatment of choroidal melanoma: a comparison of enucleation vs radiotherapy in 1596 patients. Am J Ophthalmol. 2018;193:230.
Ah-Fat FG, Sharma MC, Damato BE. Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. Eye. 1998;12(Pt 5):789–91.
Yang J, Manson DK, Marr BP, et al. Treatment of uveal melanoma: where are we now? Ther Adv Med Oncol. 2018;10:1758834018757175.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Damato, B.E. (2019). Management of Patients with Posterior Uveal Melanoma. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-17879-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-17879-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17878-9
Online ISBN: 978-3-030-17879-6
eBook Packages: MedicineMedicine (R0)